By 2030, the population in the United States aged 65 and older is expected to reach 71 million or about 20% of Americans.

As the use of obesity medications, such as GLP-1 receptor agonists, continues to expand, the American College of Lifestyle Medicine (ACLM) has released a new Obesity Medications & Lifestyle Medicine ...

Illustration of human lymphocytes. (Ruslanas Baranauskas/Science Photo Library) Defeating obesity is rarely easy. For many ...

A team led by metabolism researcher Prof Timo D. Müller at Helmholtz Munich has developed a new approach for treating obesity ...

The impact of yoga on heart health in obesity is modest, suggesting it as a complementary approach for improving metabolic ...

When children with obesity undergo weight-loss treatment, the effects have repercussions later in life and the risk of serious health problems and premature death is lower as they reach young ...

Ivim Health reports on the effectiveness of GLP-1 pills vs. Ozempic, emphasizing personalized care for obesity management.

South Florida children's hospital using weight loss drugs to treat childhood obesity ...

Big pharma is currently facing a potential “bubble effect” due to the surging demand for weight loss and diabetes drugs, as ...